|
BMS1P4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63691282750733E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.2810199829546E-13 |
| Normal-vs-Stage2 |
1.169620E-04 |
| Normal-vs-Stage3 |
2.43879999999308E-05 |
| Normal-vs-Stage4 |
1.795450E-04 |
| Stage1-vs-Stage2 |
7.621200E-01 |
| Stage1-vs-Stage3 |
1.815640E-01 |
| Stage1-vs-Stage4 |
1.438850E-01 |
| Stage2-vs-Stage3 |
2.513200E-01 |
| Stage2-vs-Stage4 |
2.037200E-01 |
| Stage3-vs-Stage4 |
8.140000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45772283133283E-13 |
| Normal-vs-AfricanAmerican |
3.777400E-04 |
| Normal-vs-Asian |
3.536800E-03 |
| Caucasian-vs-AfricanAmerican |
9.109000E-01 |
| Caucasian-vs-Asian |
9.426200E-02 |
| AfricanAmerican-vs-Asian |
8.540400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.01829680640731E-11 |
| Normal-vs-Female |
5.74607028624996E-12 |
| Male-vs-Female |
2.411600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.939700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.64011035255862E-13 |
| Normal-vs-Age(61-80Yrs) |
4.65500005208952E-09 |
| Normal-vs-Age(81-100Yrs) |
3.272200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.179800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.943200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.772200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.076640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.480200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.355600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.002200E-04 |
| Normal-vs-Grade 2 |
3.76187969663988E-12 |
| Normal-vs-Grade 3 |
4.2779000342108E-09 |
| Normal-vs-Grade 4 |
2.479400E-03 |
| Grade 1-vs-Grade 2 |
3.782300E-02 |
| Grade 1-vs-Grade 3 |
6.958500E-03 |
| Grade 1-vs-Grade 4 |
3.757900E-04 |
| Grade 2-vs-Grade 3 |
2.318600E-01 |
| Grade 2-vs-Grade 4 |
1.586420E-02 |
| Grade 3-vs-Grade 4 |
1.781440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.66611169305497E-12 |
| Normal-vs-ccB subtype |
4.09130000000868E-06 |
| ccA subtype-vs-ccB subtype |
7.536000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.02158298381983E-12 |
| Normal-vs-N1 |
1.726750E-01 |
| N0-vs-N1 |
3.305800E-01 |
|
|
